Derivation and validation of the J-CTO extension score for pre-procedural prediction of major adverse cardiac and cerebrovascular events in patients with chronic total occlusions

PLoS One. 2020 Sep 11;15(9):e0238640. doi: 10.1371/journal.pone.0238640. eCollection 2020.

Abstract

We developed a prediction model of long-term risk after percutaneous coronary intervention (PCI) for coronary chronic total occlusion (CTO) based on pre-procedural clinical information. A total of 4,139 eligible patients, who underwent CTO-PCI at 52 Japanese centers were included. Specifically, 1,909 patients with 1-year data were randomly divided into the derivation (n = 1,273) and validation (n = 636) groups. Major adverse cardiac and cardiovascular event (MACCE) was the primary endpoint, including death, stroke, revascularization, and non-fatal myocardial infarction. We assessed the performance of our model using the area under the receiver operating characteristic curve (AUC) and assigned a simplified point-scoring system. One-hundred-thirty-eight (10.8%) patients experienced MACCE in the derivation cohort with hemodialysis (HD: odds ratio [OR] = 2.55), left ventricular ejection fractions (LVEF) <35% (OR = 2.23), in-stent occlusions (ISO: OR = 2.27), and diabetes mellitus (DM: OR = 1.72). The AUC of the derivation model was 0.650. The model's performance was similar in the validation cohort (AUC, 0.610). When assigned a point for each associated factor (HD = 3, LVEF <35%, ISO = 2, and DM = 1 point), the average predicted versus the observed MACCE probability using the Japan-CTO extension score for the low, moderate, high, and very high risk groups was 8.1% vs. 7.3%, 16.9% vs. 15.9%, 22.0% vs. 26.1%, and 56.2% vs. 44.4%, respectively. This novel risk model may allow for the estimation of long-term risk and be useful in disseminating appropriate revascularization procedures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cardiac Surgical Procedures / adverse effects
  • Coronary Artery Bypass / methods
  • Coronary Occlusion / epidemiology*
  • Coronary Occlusion / physiopathology
  • Coronary Occlusion / surgery
  • Death
  • Female
  • Heart / physiopathology*
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / epidemiology*
  • Myocardial Infarction / physiopathology
  • Myocardial Infarction / surgery
  • Myocardial Revascularization / adverse effects
  • Percutaneous Coronary Intervention / adverse effects*
  • ROC Curve
  • Renal Dialysis / methods
  • Risk Factors
  • Stroke / epidemiology*
  • Stroke / physiopathology
  • Stroke / surgery

Grants and funding

Soichiro Ebisawa belongs to Endowed Department of Cardiovascular Medicine of Shinshu University supported by Medtronic Japan Co.,Ltd. Abbott Vascular Japan Co.,Ltd. Boston Scientific Japan, TERUMO CORPORATION, Cardinal Health Japan and NIPRO CORPORATION. The funders provided support in the form of salaries for Soichiro Ebisawa, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.